Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
QuidelOrtho VITROS™ Immunodiagnostic Products B·R·A·H·M·S PCT Reagent
Click to view available options
Quantity:
100 Tests
Description
Test delivers:
- High sensitivity and specificity for bacterial infection enables therapeutic decision making
- Results that are ready to be delivered to a clinicians with 96.5% First Pass Yield (without user intervention)
- Analytical performance: LOD at 0.007 ng/mL, LOQ (20% CV, observed) at 0.013 ng/mL
- Fast turnaround time: 24 minutes to first result
- Reliable solution: Not impacted by biotin interference
Indicated as an aid to be used in conjunction with clinical evaluation for:
- Risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock
- Assessing the cumulative 28-day risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock in the ICU or when obtained in the emergency department or other medical wards prior to ICU admission, using a change in PCT level over time
- Decision making on antibiotic therapy for patients with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of chronic obstructive pulmonary disease (AECOPD) – in an inpatient setting or an emergency department
- Decision making on antibiotic discontinuation for patients with suspected or confirmed sepsis
Indicated for use with the VITROS™ ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS™ 5600/XT 7600 Integrated Systems.
Specifications
Specifications
Type | Reagent |
Quantity | 100 Tests |
Range | 0.030 to 100 ng/mL (0.030 to 100 μg/L) |
Sample Size | 30 μL |
Test Time | 24 min. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction